Profile data is unavailable for this security.
About the company
BSF Enterprise PLC is a United Kingdom-based biotechnology company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people. 3DBT has three strands of three intellectual property (IP) each with a different sector focus development and revenue timeline. 3DBT’s City-mix is an animal-free cell growth agent for culturing skin, muscle and fat cells which are used for lab-grown meat and leather production. 3DBT’s Lipopeptide Etsyl actively increases collagen production in human skin cells which can be used in cosmetic and skin care products.
- Revenue in GBP (TTM)67.24k
- Net income in GBP-1.71m
- Incorporated2018
- Employees4.00
- LocationBSF Enterprise PLCGround Floor, 31 Old Burlington StreetLONDON W1S 3ASUnited KingdomGBR
- Phone+44 20 3283 4590
- Websitehttps://bsfenterprise.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Nuformix PLC | 0.00 | -341.86k |
N4 Pharma PLC | 1.95k | -1.28m |
CRISM' Therapeutics Corp | 0.00 | -1.89m |
BSF Enterprise PLC | 67.24k | -1.71m |
Oncimmune Holdings PLC | 1.21m | -3.19m |
Kanabo Group PLC | 895.00k | -7.99m |